» Articles » PMID: 15934954

Chronic Nicotine Differentially Affects the Function of Nicotinic Receptor Subtypes Regulating Neurotransmitter Release

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2005 Jun 7
PMID 15934954
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

It is known that nicotine can activate several subtypes of release-regulating presynaptic nicotinic receptors (nAChRs) including those situated on central noradrenergic, dopaminergic, cholinergic and glutamatergic axon terminals. The objective of this study was to investigate the effects of chronic administration of (-)nicotine on the function of the above autoreceptors and heteroreceptors using rat superfused synaptosomes. In hippocampal synaptosomes prelabelled with [3H]noradrenaline (NA) the nicotine-evoked overflow of [3H]NA was higher in rats treated with nicotine for 10 days (via osmotic mini-pumps) than in vehicle-treated rats. In striatal synaptosomes, prelabelled with [3H]dopamine (DA), chronic nicotine did not modify the releasing effect of nicotine. No significant change was observed in experiments with synaptosomes from nucleus accumbens prelabelled with [3H]DA. Exposure of hippocampal synaptosomes prelabelled with [3H]choline to nicotine elicited release of [3H]acetylcholine; this effect was almost abolished in synaptosomes from animals administered nicotine for 10 days, suggesting down-regulation of nicotinic autoreceptors. In hippocampal synaptosomes prelabelled with [3H]D-aspartate, the releasing effect of epibatidine following chronic nicotine treatment did not differ from that in controls. The K+-evoked exocytotic release of the neurotransmitters tested was not modified by long-term nicotine administration. The results show that chronic nicotine differentially affects the function of release-regulating nAChR subtypes.

Citing Articles

Chronic nicotine exposure is associated with electrophysiological and sympathetic remodeling in the intact rabbit heart.

Guevara A, Smith C, Caldwell J, Ngo L, Mott L, Lee I Am J Physiol Heart Circ Physiol. 2024; 326(6):H1337-H1349.

PMID: 38551482 PMC: 11381014. DOI: 10.1152/ajpheart.00749.2023.


Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP).

Forcelli P, Turner J, Lee B, Olson T, Xie T, Xiao Y Neuropharmacology. 2015; 101:46-56.

PMID: 26365569 PMC: 4681651. DOI: 10.1016/j.neuropharm.2015.09.012.


r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.

Beckmann J, Meyer A, Pivavarchyk M, Horton D, Zheng G, Smith A Neurochem Res. 2015; 40(10):2121-30.

PMID: 26227997 PMC: 4639919. DOI: 10.1007/s11064-015-1680-4.


Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals.

Marchi M, Grilli M, Pittaluga A Front Pharmacol. 2015; 6:89.

PMID: 25972809 PMC: 4413670. DOI: 10.3389/fphar.2015.00089.


α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.

Marks M, Grady S, Salminen O, Paley M, Wageman C, McIntosh J J Neurochem. 2014; 130(2):185-98.

PMID: 24661093 PMC: 4107044. DOI: 10.1111/jnc.12721.